{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T12:19:37Z","timestamp":1772281177913,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s11655-025-3822-0","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:58:22Z","timestamp":1747270702000},"page":"195-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and Safety of Qiming Granule for Nerve Injury Associated with Non-proliferative Diabetic Retinopathy: A Multicenter, Randomized, Non-inferiority, Active-Controlled Clinical Trial"],"prefix":"10.1007","volume":"32","author":[{"given":"Xue-fei","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-jin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pi-jun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-yu","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"3822_CR1","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"key":"3822_CR2","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","volume":"128","author":"ZL Teo","year":"2021","unstructured":"Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology 2021;128:1580\u20131591.","journal-title":"Ophthalmology"},{"key":"3822_CR3","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556\u2013564.","journal-title":"Diabetes Care"},{"key":"3822_CR4","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.ophtha.2018.04.007","volume":"125","author":"TY Wong","year":"2018","unstructured":"Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, Lansingh VC, et al. Guidelines on diabetic eye care: the International Council of Ophthalmology Recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology 2018;125:1608\u20131622.","journal-title":"Ophthalmology"},{"key":"3822_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.preteyeres.2018.02.002","volume":"65","author":"MT Pardue","year":"2018","unstructured":"Pardue MT, Allen RS. Neuroprotective strategies for retinal disease. Prog Retin Eye Res 2018;65:50\u201376.","journal-title":"Prog Retin Eye Res"},{"key":"3822_CR6","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.2337\/dc22-S012","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","unstructured":"American Diabetes Association Professional Practice Committee. 12. Retinopathy, neuropathy, and foot care: standards of medical care in diabetes\u20142022. Diabetes Care 2022;45:S185\u2013S194.","journal-title":"Diabetes Care"},{"key":"3822_CR7","doi-asserted-by":"publisher","first-page":"16012","DOI":"10.1038\/nrdp.2016.12","volume":"2","author":"TY Wong","year":"2016","unstructured":"Wong TY, Cheung CM, Larsen M, Sharma S, Simo R. Diabetic retinopathy. Nat Rev Dis Primers 2016;2:16012.","journal-title":"Nat Rev Dis Primers"},{"key":"3822_CR8","doi-asserted-by":"publisher","first-page":"938029","DOI":"10.3389\/fnins.2022.938029","volume":"16","author":"DI Aldosari","year":"2022","unstructured":"Aldosari DI, Malik A, Alhomida AS, Ola MS. Implications of diabetes-induced altered metabolites on retinal neurodegeneration. Front Neurosci 2022;16:938029.","journal-title":"Front Neurosci"},{"key":"3822_CR9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.oftal.2021.04.004","volume":"97","author":"M Cipres","year":"2022","unstructured":"Cipres M, Satue M, Melchor I, Gil-Arribas L, Vilades E, Garcia-Martin E. Retinal neurodegeneration in patients with type 2 diabetes mellitus without diabetic retinopathy. Arch Soc Esp Oftalmol 2022;97:205\u2013218.","journal-title":"Arch Soc Esp Oftalmol"},{"key":"3822_CR10","doi-asserted-by":"publisher","first-page":"E2655","DOI":"10.1073\/pnas.1522014113","volume":"113","author":"EH Sohn","year":"2016","unstructured":"Sohn EH, van Dijk HW, Jiao C, Kok PH, Jeong W, Demirkaya N, et al. Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc Natl Acad Sci U S A 2016;113:E2655\u2013E2664.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3822_CR11","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.4103\/0366-6999.195478","volume":"129","author":"NL Wang","year":"2016","unstructured":"Wang NL. Neurodegeneration in diabetic retinopathy: current concepts and therapeutic implications. Chin Med J 2016;129:3001\u20133003.","journal-title":"Chin Med J"},{"key":"3822_CR12","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.2337\/db09-1421","volume":"59","author":"EC Leal","year":"2010","unstructured":"Leal EC, Martins J, Voabil P, Liberal J, Chiavaroli C, Bauer J, et al. Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes. Diabetes 2010;59:2637\u20132645.","journal-title":"Diabetes"},{"key":"3822_CR13","doi-asserted-by":"publisher","first-page":"799337","DOI":"10.3389\/fendo.2022.799337","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, An X, Duan L, Jin D, Duan Y, Zhou R, et al. Effect of Chinese patent medicines on ocular fundus signs and vision in calcium dobesilate-treated persons with non-proliferative diabetic retinopathy: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 2022;13:799337.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3822_CR14","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.4103\/1673-5374.217333","volume":"12","author":"O Sim\u00f3-Servat","year":"2017","unstructured":"Sim\u00f3-Servat O, Sol\u00e0-Adell C, Bogdanov P, Hern\u00e1ndez C, Sim\u00f3 R. Mechanisms of retinal neuroprotection of calcium dobesilate: therapeutic implications. Neural Regen Res 2017;12:1620\u20131622.","journal-title":"Neural Regen Res"},{"key":"3822_CR15","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s00417-006-0318-2","volume":"244","author":"ML Ribeiro","year":"2006","unstructured":"Ribeiro ML, Seres AI, Carneiro AM, Stur M, Zourdani A, Caillon P, et al. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study. Graefes Arch Clin Exp Ophthalmol 2006;244:1591\u20131600.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3822_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1182\/blood-2020-133908","volume":"136","author":"K Weisel","year":"2020","unstructured":"Weisel K, Geils GF, Karlin L, Mollee P, Chung TH, Min CK, et al. Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of the phase 3 CANDOR study in patients with early or late relapse. Blood 2020;136:37\u201338.","journal-title":"Blood"},{"key":"3822_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000267080","volume":"23","author":"B Vojnikovic","year":"1991","unstructured":"Vojnikovic B. Doxium (calcium dobesilate) reduces blood hyperviscosity and lowers elevated intraocular pressure in patients with diabetic retinopathy and glaucoma. Ophthalmic Res 1991;23:12\u201320.","journal-title":"Ophthalmic Res"},{"key":"3822_CR18","first-page":"143","volume":"39","author":"K Han","year":"2018","unstructured":"Han K, Liu C, Shi X, Rao X. Effects of alprostadil combined with calcium dobesilate in patients with diabetic peripheral neuropathy. Neuro Endocrinol Lett 2018;39:143\u2013147.","journal-title":"Neuro Endocrinol Lett"},{"key":"3822_CR19","first-page":"241","volume":"10","author":"Retinopathy Group","year":"2018","unstructured":"Retinopathy Group, Chinese Medical Association. Expert consensus on the prevention and treatment of diabetic retinopathy. Chin J Diabet Mellit (Chin) 2018;10:241\u2013247.","journal-title":"Chin J Diabet Mellit (Chin)"},{"key":"3822_CR20","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1210\/clinem\/dgab050","volume":"106","author":"S Mudaliar","year":"2021","unstructured":"Mudaliar S, Hupfeld C, Chao DL. SGLT2 inhibitor-induced low-grade ketonemia ameliorates retinal hypoxia in diabetic retinopathy\u2014a novel hypothesis. J Clin Endocrinol Metab 2021;106:1235\u20131244.","journal-title":"J Clin Endocrinol Metab"},{"key":"3822_CR21","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s11655-009-0384-5","volume":"15","author":"XX Luo","year":"2009","unstructured":"Luo XX, Duan JG, Liao PZ, Wu L, Yu YG, Qiu B, et al. Effect of Qiming Granule on retinal blood circulation of diabetic retinopathy: a multicenter clinical trial. Chin J Integr Med 2009;15:384\u2013388.","journal-title":"Chin J Integr Med"},{"key":"3822_CR22","doi-asserted-by":"publisher","first-page":"115861","DOI":"10.1016\/j.jep.2022.115861","volume":"302","author":"Y Huang","year":"2023","unstructured":"Huang Y, Wang J, Wang Y, Kuang W, Xie M, Zhang M. Pharmacological mechanism and clinical study of Qiming Granules in treating diabetic retinopathy based on network pharmacology and literature review. J Ethnopharmacol 2023;302:115861.","journal-title":"J Ethnopharmacol"},{"key":"3822_CR23","first-page":"940","volume":"36","author":"Y Pan","year":"2021","unstructured":"Pan Y, Zhang H, Zha J, Duan K, Liu X. Improvement effect and mechanism of Qiming Granules on inflammatory response in rats with diabetic retinopathy. Northwest Pharm J (Chin) 2021;36:940\u2013945.","journal-title":"Northwest Pharm J (Chin)"},{"key":"3822_CR24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539\u2013553.","journal-title":"Diabet Med"},{"key":"3822_CR25","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","volume":"110","author":"CP Wilkinson","year":"2003","unstructured":"Wilkinson CP, Ferris FL 3rd, Klein RE, Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677\u20131682.","journal-title":"Ophthalmology"},{"key":"3822_CR26","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1007\/s00125-018-4692-1","volume":"61","author":"R Sim\u00f3","year":"2018","unstructured":"Sim\u00f3 R, Stitt AW, Gardner TW. Neurodegeneration in diabetic retinopathy: does it really matter? Diabetologia 2018;61:1902\u20131912.","journal-title":"Diabetologia"},{"key":"3822_CR27","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1136\/bjo.2009.158428","volume":"93","author":"CW Chan","year":"2009","unstructured":"Chan CW, Wong D, Lam CL, McGhee S, Lai WW. Development of a Chinese version of the National Eye Institute Visual Function Questionnaire (CHI-VFQ-25) as a tool to study patients with eye diseases in Hong Kong. Br J Ophthalmol 2009;93:1431\u20131436.","journal-title":"Br J Ophthalmol"},{"key":"3822_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1477-7525-10-89","volume":"10","author":"C Sjolander","year":"2012","unstructured":"Sjolander C, Rolander B, J\u00e4rhult J, M\u00e5rtensson J, Ahlstrom G. Health-related quality of life in family members of patients with an advanced cancer diagnosis: a one-year prospective study. Health Qual Life Outcomes 2012;10:89.","journal-title":"Health Qual Life Outcomes"},{"key":"3822_CR29","doi-asserted-by":"publisher","first-page":"12291","DOI":"10.21037\/apm-21-3147","volume":"10","author":"M Jiang","year":"2021","unstructured":"Jiang M, Lou XE, Zhang X, Nan Q, Gao X, Liu H. Development and validation of the diagnostic scale of traditional Chinese medicine syndrome elements for diabetic kidney disease. Ann Palliat Med 2021;10:12291\u201312299.","journal-title":"Ann Palliat Med"},{"key":"3822_CR30","first-page":"56","volume":"39","author":"DD Chen","year":"2018","unstructured":"Chen DD, Shuai TJ, Li J, Sun XH, Wang RY, Piao TH. Clinical efficacy of compound anisodine hydrobromide injection in the treatment of diabetic retinopathy. J Mudanjiang Med Univ (Chin) 2018;39:56\u201358.","journal-title":"J Mudanjiang Med Univ (Chin)"},{"key":"3822_CR31","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1097\/IAE.0000000000002200","volume":"39","author":"A Daruich","year":"2019","unstructured":"Daruich A, Matet A, Schalenbourg A, Zografos L. Intravitreal anti-vascular endothelial growth factor treatment at 2-month intervals reduces foveal avascular zone enlargement and vision loss in radiation maculopathy: a pilot study. Retina 2019;39:1519\u20131526.","journal-title":"Retina"},{"key":"3822_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.joco.2019.06.001","volume":"31","author":"A Mirshahi","year":"2019","unstructured":"Mirshahi A, Ghassemi F, Fadakar K, Mirshahi R, Bazvand F, Riazi-Esfahani H. Effects of panretinal photocoagulation on retinal vasculature and foveal avascular zone in diabetic retinopathy using optical coherence tomography angiography: a pilot study. J Curr Ophthalmol 2019;31:287\u2013291.","journal-title":"J Curr Ophthalmol"},{"key":"3822_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ophtha.2019.09.025","volume":"127","author":"CJ Flaxel","year":"2020","unstructured":"Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, et al. Diabetic retinopathy preferred practice pattern\u00ae. Ophthalmology 2020;127:66\u2013145.","journal-title":"Ophthalmology"},{"key":"3822_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41433-020-0961-6","volume":"34","author":"WM Amoaku","year":"2020","unstructured":"Amoaku WM, Ghanchi F, Bailey C, Banerjee S, Banerjee S, Downey L, et al. Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group. Eye (Lond) 2020;34:1\u201351.","journal-title":"Eye (Lond)"},{"key":"3822_CR35","first-page":"1026","volume":"13","author":"Diabetic Retinopathy Group of Chinese Diabetes Society","year":"2021","unstructured":"Diabetic Retinopathy Group of Chinese Diabetes Society. Chinese multidisciplinary expert consensus on the prevention and treatment of diabetic eye disease (2021 edition). J Diabet Mellit (Chin) 2021;13:1026\u20131042.","journal-title":"J Diabet Mellit (Chin)"},{"key":"3822_CR36","first-page":"158","volume":"37","author":"L Zhao","year":"2021","unstructured":"Zhao L, Yang F, Wu C, Zhang P, Jiang M. Research progress of foveal avascular zone in retinal vascular disease. Chin J Ocul Fund Dis (Chin) 2021;37:158\u2013162.","journal-title":"Chin J Ocul Fund Dis (Chin)"},{"key":"3822_CR37","doi-asserted-by":"publisher","first-page":"4874876","DOI":"10.1155\/2020\/4874876","volume":"2020","author":"W Geng","year":"2020","unstructured":"Geng W, Wang D, Han J. Trends in the retinal nerve fiber layer thickness changes with different degrees of visual field defects. J Ophthalmol 2020;2020:4874876.","journal-title":"J Ophthalmol"},{"key":"3822_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1167\/iovs.63.2.7","volume":"63","author":"X Gong","year":"2022","unstructured":"Gong X, Wang W, Xiong K, Wang L, Li W, Li Y, et al. Associations between peripapillary retinal nerve fiber layer and choroidal thickness with the development and progression of diabetic retinopathy. Invest Ophthalmol Vis Sci 2022;63:7.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3822_CR39","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1167\/iovs.17-23498","volume":"59","author":"Y Lu","year":"2018","unstructured":"Lu Y, Simonett JM, Wang J, Zhang M, Hwang T, Hagag AM, et al. Evaluation of automatically quantified foveal avascular zone metrics for diagnosis of diabetic retinopathy using optical coherence tomography angiography. Invest Ophthalmol Vis Sci 2018;59:2212\u20132221.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3822_CR40","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1080\/08820538.2021.1889612","volume":"36","author":"YS Park","year":"2021","unstructured":"Park YS, Moon H, Woo JM, Min JK. Changes in the foveal avascular zone area and retinal vessel density after anti-VEGF therapy for neovascular age-related macular degeneration. Semin Ophthalmol 2021;36:110\u2013114.","journal-title":"Semin Ophthalmol"},{"key":"3822_CR41","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.jdiacomp.2017.07.009","volume":"31","author":"P Bogdanov","year":"2017","unstructured":"Bogdanov P, Sol\u00e0-Adell C, Hern\u00e1ndez C, Garc\u00eda-Ram\u00edrez M, Sampedro J, Sim\u00f3-Servat O, et al. Calcium dobesilate prevents the oxidative stress and inflammation induced by diabetes in the retina of db\/db mice. J Diabetes Complications 2017;31:1481\u20131490.","journal-title":"J Diabetes Complications"},{"key":"3822_CR42","doi-asserted-by":"publisher","first-page":"197","DOI":"10.21037\/atm-22-2204","volume":"11","author":"X Ding","year":"2023","unstructured":"Ding X, Sun Z, Guo Y, Tang W, Shu Q, Xu G. Inhibition of NF-\u03baB ameliorates aberrant retinal glia activation and inflammatory responses in streptozotocin-induced diabetic rats. Ann Transl Med 2023;11:197.","journal-title":"Ann Transl Med"},{"key":"3822_CR43","doi-asserted-by":"publisher","first-page":"205031211667172","DOI":"10.1177\/2050312116671725","volume":"4","author":"L Lins","year":"2016","unstructured":"Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: scoping review. SAGE Open Med 2016;4:2050312116671725.","journal-title":"SAGE Open Med"},{"key":"3822_CR44","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12955-017-0732-7","volume":"15","author":"S Nickels","year":"2017","unstructured":"Nickels S, Schuster AK, Singer S, Wild PS, Laubert-Reh D, Schulz A, et al. The National Eye Institute 25-Item Visual Function Questionnaire (NEI VFQ-25)\u2014reference data from the German population-based Gutenberg Health Study (GHS). Health Qual Life Outcomes 2017;15:156.","journal-title":"Health Qual Life Outcomes"},{"key":"3822_CR45","doi-asserted-by":"publisher","first-page":"e19102","DOI":"10.1097\/MD.0000000000019102","volume":"99","author":"B Pang","year":"2020","unstructured":"Pang B, Li QW, Qin YL, Dong GT, Feng S, Wang J, et al. Traditional Chinese medicine for diabetic retinopathy: a systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e19102.","journal-title":"Medicine (Baltimore)"},{"key":"3822_CR46","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3389\/fphar.2020.00580","volume":"11","author":"M Yang","year":"2020","unstructured":"Yang M, Hu Z, Yue R, Yang L, Zhang B, Chen Y. The efficacy and safety of Qiming Granule for dry eye disease: a systematic review and meta-analysis. Front Pharmacol 2020;11:580.","journal-title":"Front Pharmacol"},{"key":"3822_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13020-020-00380-4","volume":"15","author":"X An","year":"2020","unstructured":"An X, Jin D, Duan L, Zhao S, Zhou R, Lian F, et al. Direct and indirect therapeutic effect of traditional Chinese medicine as an add-on for non-proliferative diabetic retinopathy: a systematic review and meta-analysis. Chin Med 2020;15:99.","journal-title":"Chin Med"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-025-3822-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-025-3822-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-025-3822-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T11:35:59Z","timestamp":1772278559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-025-3822-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["3822"],"URL":"https:\/\/doi.org\/10.1007\/s11655-025-3822-0","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"5 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}